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Different pigmentary characteristics as well as different pa-
rameters of sun exposure have previously been identified as 
risk factors for developing cutaneous melanoma. The aim of 
the present study was to identify significant risk factors, de-
termine the related magnitude of their estimated relative 
risks, and define criteria for the detection of persons at risk. 
Five hundred thirteen melanoma patients and 498 controls 
matched for age and sex underwent a whole-body examina-
tion for the number and type of melanocytic lesions and were 
interviewed on ultraviolet exposure and other potential risk 
factors. The total number of common melanocytic nevi on all 
body sites represented the most important risk factor in mul-
tiple logistic regression analysis with a relative risk of7.6 for 
subjects with more than 100 versus no more than 10 melano-
cytic nevi. Other significant independent risk factors were 
the number of atypical melanocytic nevi (relative risk, 6.1 for 
at least 5 melanocytic nevi versus none), the number of ac-
D uring the last decades, a sharp increase in the inci-dence of cutaneous melanomas (eM) has been re-ported in the white populations of western indus-trial nations. In West Germany, the eM incidence has doubled every 12 - 15 years [1] . The fact that 
advanced eM is still incurable made early detection one of the main 
goals in the fight to reduce increasing eM mortality. Primary pre-
vention as well as the identification of factors responsible for the 
marked increase in eM have likewise become a focal point of 
interest. 
Risk factors for the development of eM have been examined in a 
series of case-control studies during the last ten years. Primarily, 
pigmentary traits like skin type and hair color and parameters of sun 
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tinic lentigines (relative risk, 3.5 for many versus none), hair 
color, skin type, and reported melanocytic nevus growth. No 
single parameter of sun exposure was significantly related to 
melanoma risk in the multivariate analysis. Groups with an 
estimated relative risk between 1 and 121.0 were distin-
guished by considering common and atypical melanocytic 
nevi as well as actinic lentigines as the decisive criteria. In 
conclusion, even without any information on the case his-
tory, whole-body examination and diagnosis of pigmented 
lesions was found to be an effective strategy for identifying 
persons at risk of developing melanoma. Furthermore, clini-
cal recognition of at least 5 atypical melanocytic nevi without 
histologic examination is a key for identifying subjects at 
high risk. Key words: melanoma/risk factors/melanocytic nevi/ 
atypical melanocytic nevi/actinic lentigilfes/UV irradiation. 
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exposure including sunburns have been detected as risk factors for 
eM devel?pment [2-5]. Additionally, the number and type of 
melanocyuc lesIOns were identified as major risk factors for the 
devel0rment of eM, particularly common melanocytic nevi (MN) 
[6 -14. In the few investigations differentiating between common 
MN, atypical MN, and actinic lentigines, all three kinds of melano-
cytic lesions proved to be markers of an increased eM risk [13,14]. 
So ~ar, ~ublished studies have differed in their proposals concerning 
major nsk factors for the assessment of melanoma risk. 
Until now, only a few studies with rather small study groups have 
carried out a differentiated and exact documentation of pigmented 
lesions on all body sites [11,13,14], whereas large epidemiologic 
studies have counted only MN on the arms [7,10,12]. However, the 
importance of different melanocytic lesions for an accurate risk 
assessment can only be adequately determined on the basis of exact 
definitions for the type of melanocytic lesions and by examinations 
carried out by experienced clinicians. It was therefore the aim of the 
present study to perform an exact documentation of all different 
melanocytic lesions on all body sites in large study groups and, 
additionally, to record detailed data on possible further risk factors. 
The case-control study on the risk of eM development presented 
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here is, to date, the largest published study with dermatologic 
whole-body examinations. 
SUBJECTS AND METHODS 
Melanoma Patients The present study prospectively included CM pa-
tients who had presented for diagnosis from January 1990 until June 1991 at 
the nine cooperating university departments of dermatology (the documen-
tation time was shorter at three centers). The historathologic CM diagnosis 
was established by the dermatohistopathologists 0 the cooperating centers. 
The study included a total of513 CM patients (98% participation rate), 230 
male (44.8%) and 283 female (55 .2%), with a mean age of 55.7 years (SD 
± 16.0 years). 41.7% of the melanomas were superficially spreading mela-
nomas, 15.6% were nodular melanomas, 11.9% were lentigo maligna mela-
nomas, 6.8% were acrolentiginous melanomas, 4.7% were not classifiable, 
and 19.3% were not definitely classified. Levell melanomas were found in 
9%, level II in 17.9%, level III in 36.2%, level IV in 32.5%, and level V in 
4.4% (missing data in 33 cases). 91.4% of the CM patients were inpatients; 
8.6% were outpatients. 
Control Subjects Four hundred ninety-eight non-melanoma patients of 
the participating dermatologic departments were included as controls (96% 
participation rate) to permit an adequate dermatologic whole-body exami-
nation. Control subjects were matched by sex and age (± 5 years) within 
each of the cooperating centers to the CM patients of the same center; no 
appropriate controls were found for 15 CM patients. Reasons for excluding 
controls from the study were as follows : 1) presentation for pigmented nevi 
or 2) skin cancer, 3) phototherapy in case history, 4) foreign descent. The 
exclusion criteria 3 and 4 were also applied to CM patients. To study an 
ethnically homogeneous collective, only subjects of German, Austrian, and 
Swiss descent were included. One hundred eighteen age- and sex-matched 
individuals were not included in the study for the aforementioned reasons 
(reasons for exclusion: 1,21.5%,2,39.2%,3,32.3%,4, 7%). 89.3% of the 
controls were inpatients and 10.7% were outpatients. Most of them 
presented with allergic disorders and eczematous diseases (32.1 %), followed 
by infectious skin diseases and leg ulcers (30.3%), psoriasis and classical 
dermatologic diseases (21 .9%), benign neoplasias (4.1 %), and miscellaneous 
conditions (11.6%). Among the control subjects were 221 male (44.4%) and 
277 female (55.6%) subjects, with a mean age of 54.8 years (SD ± 16.1 
years). 
Diagnostic Criteria for Pigmented Lesions Pigmented lesions with a 
diameter of at least 2 mm were classified as common melanocytic nevi if they 
were either a) macular, brown to dark brown, and sharply bordered Uunc-
tional nevi), b) papular, regularly, and sharply bordered as well as light to 
dark brown (compound nevi), or c) papular to nodular and skin-colored to 
erythematous (dermal nevi). The clinical diagnosis of atypical melanocytic 
nevi was established when at least three of the following characteristics were 
present: 1) diameter ~ 5 mm, 2) ill-defined borders, 3) irregular margin, 4) 
varying shades ·in the lesion, and 5) simultaneous presence of papular and 
macular components. The lower limit of diameter was also at least 2 mm for 
atypical MN. Lesions were classified as congenital nevus-like melanocytic 
nevi when their diameter was greater than 10 mm and when they addition-
ally fulfilled three of the following criteria: 1) hypertrichosis, 2) well-
defined borders, 3) regular margin, 4) uniform mostly black color, and 5) 
papular to papillomatous surface. Diagnosis of actinic lentigines was estab-
lished in lesions with only a macular surface, light brown or grey brown 
color, and well-defined borders with sometimes finely irregular margins. 
Before the start of the study, the diagnostic criteria for the various pigmented 
lesions were defined in a consensus workshop with all examiners from the 
different centers and were illustrated in a photo documentation that served as 
diagnositic guideline (HPS, CG). 
Dermatologic Examinations All study subjects underwent a whole-
body examination in which dermatologists familiar with the examination 
criteria recorded the pigmented lesions. Common and atypical MN were 
counted separately according to 12 body regions (excluding the scalp and the 
genitoanal region) and documented on a standardized computer form. Con-
gen ital nevus like MN were likewise recorded (number and size). In addi-
tion, the number of Becker's nevi, nevi spili, cafe-au lait spots, and halo nevi 
were registered. The number of actinic lentigines were classified in catego-
ries of none, few, and many according to a graphic chart. The presence of 
actinic keratoses and actinic elastosis was documented. Pigmentation char-
acteristics such as eye color, hair color (at the age of20), and skin pigmenta-
tion on the trunk were likewise recorded. 
"-
Interviews Prior to the physical examination, all study subjects were in-
terviewed by the investigators using a standardized questionnaire. Data were 
recorded with regard to profession, occupational sun exposure, recreational 
sun exposure, especially the type and duration of sun exposure during the last 
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Figure 1. CART analysis of relative risks for developing cutaneous mela-
noma by combining several risk factors. Estimated relative risks were calcu-
lated in comparison to the group with lowest risk; in brackets, 95% confi-
dence intervals. 
2 years, the use of sunlamps or sunbeds, the number of painful sunburns 
throughout bfe, the number of sunburns in the last 5 years, and before and 
after completing the age of 20. In addition, the study subjects were asked to 
state whether new nevi had appeared in the past 5 years or existing ones had 
increased in size (independently of the development of CM). Study subjects 
were also asked to specify the presence offreckles in their youth (age 10-20) 
o? the basis of a graphic chart (none, few, a moderate number, many). 
FlIlally, the number of blood relatives diagnosed as having melanoma or skin 
cancer and those with large numbers of MN were recorded. 
Statistical Analysis Differences in the frequency of different variables in 
CM patients and control subjects were initially bivariately tested by the 
chi-square test. All p values calculated were two sided. Factors with p values 
less than 0.1 were entered in a multifactorial stepwise logistic regression 
analYSIS that was performed using the EGRET statistical package [15]. The 
following factors were included in the final logistic model: number of com-
mon MN, number of atypical MN, frequency of actinic lentigines, hair 
color, skill type, and the anamnestic statement concerning pigmented nevus 
growth. Odds ratios and their 95% confidence intervals were determined by 
the logistic model and interpreted as relative risks for developing CM in this 
context. Classification of the study collective in risk groups was done by 
classification and regression tree analysis (CART) [16]. Thereby, the total 
collective as well as the subgroups were investigated at every step of the 
analysis to determine which variable yielded the most significant subdivision 
into a higher and a lower risk group. 
RESULTS 
Bivariate Analysis Bivariate comparison of the physical exami-
nation findings revealed significant differences between eM pa-
tients and control subjects for the number of common and atypical 
MN, the number of actinic lentigines, hair color, eye color, and the 
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Table I. Multiple Logistic Regression Analysis of Risk Factors and Relative Risks for Developing CM' 
Controls 
Relative Risk 
Cases 
Risk Factor (496) (476) Unadjusted [95% CIlb Adjusted [95% CIl 
Common melanocytic nevi 
0-10 151 255 
11-50 206 183 1.9 [1.4; 2.5] 1.7 [1.3; 2.4] 
51-100 72 27 4.5 [2.8; 7.3) 3.7 [2.1 ; 6.5) 
>100 67 11 10.3 [5.3; 20.1] 7.6 [3 .5; 16.2] 
Atypical melanocytic nevi 
None 313 394 1 
1-4 126 76 2.1 [1.5; 2.9] 1.6 [1.1;2.3] 
2:5 57 6 12.0 [5.1; 28.1) 6.1 [2.3; 16.1] 
Actinic lentigines 
None 126 200 1 
Few 282 236 1.9 [1.4; 2.5] 2.1 [1.5; 2.9) 
Many 88 40 3.5 [2.3; 5.4] 3.4 [2.1; 5.4] 
Hair color 
Black or brown 175 220 1 
Blond 277 243 1.4 [1.1 ; 1.9] 1.4 [1.0; 1.9J 
Red 44 13 4.3 [2.2; 8.2] 3.5 [1.7; 7.2] 
Reported growth of MN 
1 No 334 292 
Yes 74 19 3.4 [2.0; 5.8] 2.3 [1.3; 4.1J 
Skin type 
3 or 4 259 305 1 
1 or 2 237 171 1.6 [1.3; 2.1] 1.4 [1.0; 1.8] 
'The logistic model included total number of common MN, total number of atypical MN, actinic lentigines, hair color, skin type, and reported growth of MN. 
• [95% CI], 95% confidence intervals. 
presence of actinic elastosis. The number of common MN on .the 
entire body (mean, CM patients 46.3, control subjects 19.4; median, 
21.0 versus 9.0) was found different with the highest statistical 
significance, followed by the number of atypical MN (mean, 2.0 
versus 0.6). Atypical MN were found in 36.6% of CM patients and 
in 17.1 % of controls. There was only little concordance with the 
prevalence of large melanocytic nevi (2: 5 mm), which occured in 
54.4% of CM patients and 31.3% of controls. No significant differ-
ences between CM patients and control subjects were found for 
other pigmented lesions. 
The interviews also revealed significant differences between CM 
patients and control subjects. The prevalence of freckles in adoles-
cence was higher in CM patients than in control subjects. Also, the 
light-sensitive skin types 1 or 2 were found more frequently in CM 
patients than in control subjects. CM patients stated significantly 
more often that new pigmented nevi had occurred independent of 
the development of their CM or that pre-existing pigmented nevi 
had grown in size. For most of the sun-exposure parameters there 
were no significant differences between CM patients and control 
subjects. Merely the number of sunburns before the age of 20 was 
significantly higher in CM patients (p < 0.05). None of the CM 
patients or controls had more than one blood relative with CM. 
Fifteen CM patients and five controls reported one blood relative 
with a diagnosis of CM (p < 0.05). 
Multiple Logistic Regression Analysis From a total of 28 fac-
tors included in stepwise logistic regression analysis six had a signif-
icant influence (p < 0.05) on the RR of developing CM. The order 
of their importance using stepwise regression was: the total number 
of common MN and the number of atypical MN as the most impor-
tant factors , followed by the number of actinic lentigines, hair color, 
skin type, and reported pigmented nevus growth (Table I). 
The number of common MN was the strongest indicator of an 
• increased risk for the development of CM. Compared to subjects 
with 0-10 MN over all body areas, those with 50-100 MN already 
had an increased risk by the factor of 3.7 (after controlling for the 
five other significant variables), and those with more than 100 nevi 
by the factor of 7.6. The risk increased steadily with increasing 
numbers of common MN. A different characteristic was observed 
for the number of atypical MN. Compared to subjects without 
atypical nevi, those with 1-4 atypical MN had a RR increase by the 
factor of 1.6, but those with five and more nevi had a marked RR 
increase by the factor of 6.1. No additional risk increase was ob-
served for higher numbers of atypical nevi after controlling for 
potential confounding. 
CART Analysis Determination of decisive factors for subclassi-
fication of different risk groups was done by CART analysis. This 
type of analysis identifies important combinations of risk factors in 
the study collective and estimates the associated magnitudes of RR 
(Fig 1). TI?e.number of common MN (:5 50; > 50) was the parame-
ter that dIVIded the total collective with the highest significance 
into two subgroups with differing CM risks. The manifestation of 
actinic lentigines (none; few and many) fo llowed in this analysis as 
the second most important parameter. The third determining pa-
rameter was the presence of atypical MN and an additional subdivi-
sion of the number of common MN (0 -1 0; 11- 50) in one sub-
group. The subclassification was terminated when no ",dditional 
variable was determined to significantly subdivide the analyzed col-
lectives. An extraordinarily high risk was observed in individuals 
with at least 5 atypical MN in combination with actinic lentigines 
and more than 50 coml11on MN (RR = 121). Skin type merely 
played a role in risk assessment for patients with a negligible number 
of common MN and no actinic lentigines . A different strategy of 
CART analysis adjusting for age and sex after the first step was 
additionally performed (data not given). The same factors became 
significant in this adjusted CART analysis and the main differences 
were a lower impact of actinic lentigines as well as the result that 
exclusively the difference between 0-4 and 2: 5 atypical MN was 
significant. 
Risk groups for the development of CM were defined on the basis 
of the CART analysis (Table II). Individuals presenting merely with 
actinic lentigines or skin type 1 and 2 as risk factors had a low risk of 
developing CM (factor 2- 3). An already moderate risk (factor 3 -6) 
was observed in those with more than 50 common MN, with atypi-
cal MN, or with 11-50 MN and the additional occurence of actinic 
lentigines. A clearly increased risk (factor 10- 20) was found in 
patients with more than 50 common MN and the additional occur-
ence of either atypical MN or actinic lentigines. A markedly in-
creased risk (factor greater than 100) was observed in individuals 
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Table II. Risk Assessment Scheme for the Combination of 
Different Risk Factors and Estimated Relative Risks (RR) 
Relative Risk 
of Developing eM 
Low (RR = 2-3) 
Moderate 
(RR = 3-6) 
Increased 
(RR = 10-20) 
Markedly increased 
(RR> 100) 
Common 
MN 
11-50 
>50 
>50 
> 50 
>50 
Actinic Atypical 
Lentigines MN Skin Type 
Yes 
1-2 
Yes 
Yes 
Yes 
Yes 
Yes 2:5 
with more than 50 MN, at least five atypical MN, and the additional 
prevalence of actinic lentigines. 
DISCUSSION 
The present multicenter case-control study included 513 CM pa-
tients prospectively recorded by nine university departments of der-
matology in Germany, Austria, and Switzerland. Study centers (and 
their periphery) were selected to obtain a balanced ratio between 
urban and rural areas. Age and sex distribution, histologic mela-
noma subtypes, Breslow's thickness, and Clark's level of the present 
collective were representative for data of 3751 melanoma patients 
obtained from 41 centers in these countries recorded by the Central 
Malignant Melanoma Registry during the years 1989 -1991 (data 
not given). Control subjects were selected from the participating 
centers. To reduce potential bias due to this selection, we excluded 
patients presenting because of pigmented moles or skin cancer, with 
a case history of phototherapy and patients of foreign descent. Inter-
estingly, all published studies with whole-body examinations like-
wise used hospital-based control subjects [11,13,14,17], and inclu-
sion of population-based controls in this type of study remains a 
future objective. 
N umber and type of melanocytic lesions over the entire body had 
the greatest importance for determining the RR of developing CM. 
Independently of each other, the number of common MN, atypical 
MN, and actinic lentigines were risk factors that predicted the risk 
of developing CM with the highest significance of all test parame-
ters. The parameters recorded in the case history were of secondary 
importance for risk assessment. Hair color at the age of 20, the 
incidence of freckles in adolescence, and the skin type had the high-
est significance (p < 0.001 in bivariate analysis), followed by re-
~orted development of new moles as well as reported mole growth 
(p < 0.01) and finally sunburns before 20 and report of affected 
blood relatives (p < 0.05). Previous case-control studies on the risk 
of CM development that included both a whole-body examination 
and an extensive interview also demonstrated the superiority of 
clinical examination findings for risk assessment over case history 
data [11,13,14,17]. 
The CM risk showed an almost linear increase with the number 
of common acquired MN over the entire body. Common MN were 
first identified as major risk factors for developing CM by their 
self-reported frequencies by study subjects [6], later on by MN 
counts on the arms [7,10,12], and finally by their assessment on all 
body sites [9,11,13,14]. We could demonstrate in a previous study 
that the latter method yields the best risk estimations [18]. In the 
present study, the subclassification into groups with 10, 50, and 100 
MN turned out to be the best subdivision for CM risk assessment. 
The adjusted multivariate analysis revealed that the risk approxi-
mately doubles above each of these numbers. Similar observations 
have been reported by other investigators, although the magnitude 
of odds ratios (OR) determined in case-control studies varied widely 
according to the study population and to sample sizes [9,11,13,14]. 
In the few investigations differentiating between common and 
atypical MN, the latter have already been identified as an indepen-
dent risk factor for developing CM [11,13,14,17]. All these studies 
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defined atypical MN exclusively by their clinical appearance with-
out histologic examination; this study followed the same concept. 
The presence of even a few atypical MN [1-4] led to a slightly 
increased CM risk (factor 1.6). A qualitative breakpoint has been 
observed with 5 or more atypical nevi. In this case, the RR increased 
by the factor of 6.1 in the adjusted calculation. There was no further 
increase in the RR of CM development with higher numbers of 
atypical MN. This finding indicates that preferentially the atypical 
nevus syndrome with five or more atypical MN may be relevant for 
CM risk assessment. The magnitude of RR determined here is in 
good agreement with the factor of seven reported for the presence of 
sporadic "dysplastic" nevus syndrome in the US population [19]. It 
is still a matter of debate, if it is possible to give also a histologic 
definition of this type of MN [20,21], and this problem has to 
be further elucidated by combined epidemiologic and histologic 
studies. 
The third important factor for CM risk assessment was the pres-
ence of actinic lentigines. Even a few actinic lentigines were asso-
ciated with an increase in the relative CM risk by a factor of 2.1, 
many actinic lentigines with an increase by a factor of3.4. A signifi-
cant increase in the RR with an increasing number of actinic lenti-
gines that is independent of the number of MN was also described in 
the few previous studies examining this feature [12-14]. In the 
present study, freckles in childhood and adolescence as well as ac-
tinic lentigines at the time of the examination were recorded sepa-
rately. In the bivariate analysis of this study, a history of freckles in 
childhood as well as the presence of actinic lentigines at the time of 
examination were significantly associated with an increased RR for 
CM. Both parameters were highly significantly related with each 
other (p < 0.0001) . In the multiple logistic regression analysis, the 
history of freckles in childhood was no longer included in the model 
because the presence of actinic lentigines was found to be the better 
risk indicator. 
Hair color and skin type were identified as additional significant 
independent risk factors. Several large epidemiologic investigations 
revealed that the pigmentary traits (skin type, hair color, eye color) 
are also risk factors for the development of CM [22-25]. In the 
present study, blond compared to brown or black hair as well as a 
light-sensitive skin type (type 1 or 2 versus 3 or 4) were associated 
with an increased RR by the factor of 1.4. Red hair found in 9% of 
CM cases and 3% of control subjects was associated with a clearly 
higher risk increase by the factor of 3.5. This magnitude of risk 
increase for red hair was also observed in a previous case-control 
study of the German Central Malignant Melanoma Registry [26]. 
Among all of the parameters determined as indicators for sun 
exposure, a significant association with CM risk was only found for 
the number of sunburns before the age of20 in the bivariate analysis, 
but this was no longer a significant independent risk factor in the 
multivariate model. However, the absence of a significant relation 
between sun exposure parameters, including sunburns before the 
age of20, and the risk for developing CM does not exclude the sun 
as a risk factor. SeveraL studies have proposed a significant correla-
tion between the number of common and atypical MN and sun 
exposure, particularly sunburns [27 -29]. An interpretation of the 
results of the multivariate analysis can therefore be that the number 
of MN is more important for CM risk assessment than the reported 
sunburns before the age of 20. Furthermore, the results of other 
studies have shown that the number of life-long sunburns competes 
with the skin type for a significant relation to the CM risk [30]. Still, 
the skin type itself is no risk factor but becomes one in connection 
with UV exposure. 
The importance of various risk factors for the identification of 
high-risk individuals was more clearly defined by the CART analy-
sis. In the CART analysis as well, the total number of common MN 
was the most important parameter, and 50 MN were the best 
threshold value for determining CM risk patients. The second most 
important parameter for risk assessment in both subgroups 
(:5 50 MN, > 50 MN) was the presence of actinic lentigines, fol-
lowed by the presence of atypical MN. Already one or even a few 
atypical MN were important for risk assessment in subjects without 
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actlntC lentigines. An additionally increased risk in subjects with 
more than 50 common nevi and actinic lentingines, however, was 
only found when they had five or more atypical MN (RR = 121.0 
[1 5 .8,924.5]) . These subjects belong to the group with the sporadic 
type of the atypical MN syndrome. The large confidence interval in 
the group with these characteristics is due to the small number of 
controls (34 CM patients and only one control). This implies that 
this risk factor constellation is extremely rare in the general popula-
tion and was only found in 0.2% of controls. We decided not to 
adjust the CART analysis for age and sex after the first step of 
subclassification. Particularly actinic lentigines increase in number 
w ith increasing age and by adjustment for age their importance for 
detecting persons at risk may be underestimated. 
Risk assessment on the basis of clinically detectable pigmented 
nevi over the body has the advantage of good reproducibility of test 
results. Agreement between different clinicians familiar with pig-
mented lesions was 85 - 90% in a study on this issue so that MN may 
be regarded as markers for risk assessment with a highly reliable 
reproducibility [31]. 
We conclude that the characteristics obtained through dermato-
logic whole-body examination are clearly superior to case history 
data as risk indicators for the development of CM. Recognition of 
the numbers of common and atypical MN and of the frequency of 
actinic lentigines and the application of our proposed risk assess-
ment scheme aIlows the trained physician immediate identification 
of persons at risk. The magnitudes of RR for the different risk 
factors determined in the present study may not apply to other 
geographic areas, and similar studies elsewhere are required. Fi-
nally, the present study confirms that clinical recognition of the 
atypical mole syndrome is a key for identifying persons at high 
risk of developing CM independently of a specific histological 
diagnosis. 
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(Director, H. H. Wo!fj; M.D.) , Berlill-Steglitz (Director, C. E. Or[aJJos, M.D.), 
Hamburg (Director, J. RiJJg, M.D., Ph.D.) , BOJJII (Director, H. W. Kreysel, 
M.D .), Zarich (Director, G. Burg, M.D.) , Homburg (Direc/or, H. Zaul" M.D.) , 
and Heidelberg (Director, D. Petzoldt, M.D')' The order oj citatioll refers to tlte 
qua ntity oj cases submitted by tlte cooperatillg cell/ers. 
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